Olmesartan/amlodipine vs olmesartan/hydrochlorothiazide in hypertensive patients with metabolic syndrome: the OLAS study

Total and High-Molecular-Weight Adiponectin and Resistin in Relation to the Risk for Type 2 Diabetes in Women

(2013) Christin Heidemann et al.   ANNALS OF INTERNAL MEDICINE

The rise and fall of the metabolic syndrome

(2010) K. Borch-Johnsen et al.   DIABETOLOGIA

Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 Trials

(2009) David S. Wald et al.   AMERICAN JOURNAL OF MEDICINE

Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document

(2009) Giuseppe Mancia et al.   BLOOD PRESSURE

The Choice of Thiazide Diuretics

(2009) Norman M. Kaplan   HYPERTENSION

Differential Effects Between a Calcium Channel Blocker and a Diuretic When Used in Combination With Angiotensin II Receptor Blocker on Central Aortic Pressure in Hypertensive Patients

(2009) Yoshio Matsui et al.   HYPERTENSION

Impact of Abdominal Obesity on Incidence of Adverse Metabolic Effects Associated With Antihypertensive Medications

(2009) Rhonda M. Cooper-DeHoff et al.   HYPERTENSION

New Onset Diabetes During Antihypertensive Therapy

(2008) M. H. Alderman   AMERICAN JOURNAL OF HYPERTENSION

The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study

(2008) Steven G. Chrysant et al.   CLINICAL THERAPEUTICS

Risk factor assessment for new onset diabetes: literature review

(2008) George Bakris et al.   DIABETES OBESITY & METABOLISM

Risks for type-2 diabetes associated with the metabolic syndrome and the interaction between impaired fasting glucose and other components of metabolic syndrome

(2008) Shi-Jun Liu et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Hydrochlorothiazide, but not Candesartan, Aggravates Insulin Resistance and Causes Visceral and Hepatic Fat Accumulation

(2008) Jan W. Eriksson et al.   HYPERTENSION

Effect of Valsartan Addition to Amlodipine on Insulin Sensitivity in Overweight-Obese Hypertensive Patients

(2008) Roberto Fogari et al.   INTERNAL MEDICINE

Combined Therapy With a Calcium Channel Blocker and an Angiotensin II Type 1 Receptor Blocker

(2008) George L. Bakris   Journal of Clinical Hypertension

s-ICAM-1 and s-VCAM-1 in healthy men are strongly associated with traits of the metabolic syndrome, becoming evident in the postprandial response to a lipid-rich meal

(2008) Diana Rubin et al.   Lipids in Health and Disease

Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients

(2008) Kenneth Jamerson et al.   NEW ENGLAND JOURNAL OF MEDICINE